Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 2/20 | 0.56 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.56 |
| ▸ | GPR119 | Q8TDV5 | 5/20 | 0.54 |
| ▸ | CKS1B | P61024 | 2/20 | 0.50 |
| ▸ | SKP1 | P63208 | 2/20 | 0.50 |
| ▸ | SKP2 | Q13309 | 2/20 | 0.50 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.48 |
| ▸ | RET | P07949 | 4/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.46 |
| ▸ | OGFRL1 | Q5TC84 | 1/20 | 0.46 |
| ▸ | ADK | P55263 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2366254 | 0.94 | DDB1 (0.59) | DDB1CRBNGPR119CKS1BSKP1 | |
| SCHEMBL25319235 | 0.90 | GPR119 (0.57) | DDB1CRBNGPR119CKS1BSKP1 | |
| SCHEMBL29165899 | 0.86 | GPR119 (0.57) | DDB1CRBNGPR119HPGD | |
| SCHEMBL28961480 | 0.84 | DDB1 (0.52) | DDB1CRBNGPR119CKS1BSKP1 | |
| SCHEMBL5462598 | 0.82 | GPR119 (0.58) | DDB1CRBNGPR119SMN1; SMN2 | |
| SCHEMBL31532333 | 0.81 | GPR119 (0.47) | DDB1CRBNGPR119CKS1BSKP1 | |
| SCHEMBL25325974 | 0.81 | GPR119 (0.47) | DDB1CRBNGPR119CKS1BSKP1 | |
| SCHEMBL265889 | 0.81 | MAP4K4 (0.60) | DDB1CRBNGPR119CKS1BSKP1 | |
| SCHEMBL29612182 | 0.81 | MAP4K4 (0.60) | DDB1CRBNGPR119CKS1BSKP1 | |
| SCHEMBL25326401 | 0.80 | GPR119 (0.47) | DDB1CRBNGPR119CKS1BSKP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4543895-A1 | NOVEL IRON-BASED COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF, AND USE THEREOF AS CATALYSTS | Université Paris-Saclay (FR) | 2025-04-30 | — | — | EP | disclosed |
| US-12076715-B1 | Synthesis and characterization of air-stable iron-based catalysts for Suzuki-Miyaura cross-coupling reactions of alkyl halides and aryl boronic esters | THE TRUSTEES OF BOSTON COLLEGE (MA) | 2024-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12076715-B1 | Synthesis and characterization of air-stable iron-based catalysts for Suzuki-Miyaura cross-coupling reactions of alkyl halides and aryl boronic esters | NBAS, BLVRB, TFRC | DDB1 1942/4885CRBN 234/4885GPR119 1443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.